Emmaus Life Sciences Files 8-K on Financials

Ticker: EMMA · Form: 8-K · Filed: Apr 14, 2025 · CIK: 822370

Emmaus Life Sciences, INC. 8-K Filing Summary
FieldDetail
CompanyEmmaus Life Sciences, INC. (EMMA)
Form Type8-K
Filed DateApr 14, 2025
Risk Levelmedium
Sentimentneutral

Sentiment: neutral

Topics: financial-results, corporate-actions

TL;DR

Emmaus Life Sciences dropped an 8-K on financials, check it out.

AI Summary

Emmaus Life Sciences, Inc. filed an 8-K on April 14, 2025, reporting on its results of operations and financial condition. The filing also includes financial statements and exhibits. The company was formerly known as MYnd Analytics, Inc., CNS RESPONSE, INC., and STRATIVATION, INC., with its most recent name change on December 11, 2015.

Why It Matters

This 8-K filing provides an update on Emmaus Life Sciences' financial performance and condition, which is crucial information for investors to assess the company's health and future prospects.

Risk Assessment

Risk Level: medium — As an 8-K filing concerning financial results, it carries a medium risk as it could reveal positive or negative performance impacting the stock.

Key Players & Entities

FAQ

What specific financial information is being reported in this 8-K?

The 8-K filing indicates it pertains to 'Results of Operations and Financial Condition' and includes 'Financial Statements and Exhibits'.

When was the earliest event reported in this filing?

The earliest event reported is dated April 14, 2025.

What is Emmaus Life Sciences, Inc.'s state of incorporation?

Emmaus Life Sciences, Inc. is incorporated in Delaware.

What was Emmaus Life Sciences, Inc. previously named?

Emmaus Life Sciences, Inc. was formerly known as MYnd Analytics, Inc., CNS RESPONSE, INC., and STRATIVATION, INC.

What is the business address of Emmaus Life Sciences, Inc.?

The business address is 21250 Hawthorne Boulevard, Suite 800, Torrance, CA 90503.

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on April 14, 2025 regarding Emmaus Life Sciences, Inc. (EMMA).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing